<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="ro">
	<id>https://wiki.tradeville.ro/index.php?action=history&amp;feed=atom&amp;title=BriaCell_Therapeutics_Corp.</id>
	<title>BriaCell Therapeutics Corp. - Revizia istoricului</title>
	<link rel="self" type="application/atom+xml" href="https://wiki.tradeville.ro/index.php?action=history&amp;feed=atom&amp;title=BriaCell_Therapeutics_Corp."/>
	<link rel="alternate" type="text/html" href="https://wiki.tradeville.ro/index.php?title=BriaCell_Therapeutics_Corp.&amp;action=history"/>
	<updated>2026-04-20T11:33:52Z</updated>
	<subtitle>Istoricul versiunilor pentru această pagină din wiki</subtitle>
	<generator>MediaWiki 1.39.2</generator>
	<entry>
		<id>https://wiki.tradeville.ro/index.php?title=BriaCell_Therapeutics_Corp.&amp;diff=408937&amp;oldid=prev</id>
		<title>Admin: Pagină nouă: Pagina dedicata companiei BriaCell Therapeutics Corp. listata cu simbolul US.BCTX  ==Descriere companie== BriaCell Therapeutics Corp. (www.briacell.com) is a clinical stage immunotherapy company. The Company is focused on developing treatments that boost the ability of the body’s own cancer-fighting cells to destroy cancerous tumors. Its lead drug candidate, Bria-IMT, is a targeted immunotherapy being developed for the treatment of advanced breast cancer. The Company is foc...</title>
		<link rel="alternate" type="text/html" href="https://wiki.tradeville.ro/index.php?title=BriaCell_Therapeutics_Corp.&amp;diff=408937&amp;oldid=prev"/>
		<updated>2024-09-18T13:41:37Z</updated>

		<summary type="html">&lt;p&gt;Pagină nouă: Pagina dedicata companiei BriaCell Therapeutics Corp. listata cu simbolul US.BCTX  ==Descriere companie== BriaCell Therapeutics Corp. (www.briacell.com) is a clinical stage immunotherapy company. The Company is focused on developing treatments that boost the ability of the body’s own cancer-fighting cells to destroy cancerous tumors. Its lead drug candidate, Bria-IMT, is a targeted immunotherapy being developed for the treatment of advanced breast cancer. The Company is foc...&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Pagină nouă&lt;/b&gt;&lt;/p&gt;&lt;div&gt;Pagina dedicata companiei BriaCell Therapeutics Corp. listata cu simbolul US.BCTX&lt;br /&gt;
&lt;br /&gt;
==Descriere companie==&lt;br /&gt;
BriaCell Therapeutics Corp. (www.briacell.com) is a clinical stage immunotherapy company. The Company is focused on developing treatments that boost the ability of the body’s own cancer-fighting cells to destroy cancerous tumors. Its lead drug candidate, Bria-IMT, is a targeted immunotherapy being developed for the treatment of advanced breast cancer. The Company is focused on conducting Phase I/IIa clinical trial of Bria-IMT in a combination study with immune checkpoint inhibitors such as the Incyte drugs retifanlimab, an anti-PD-1 antibody similar to pembrolizumab, and epacadostat, an orally bioavailable small-molecule inhibitor of indoleamine 2,3-dioxygenase 1 (IDO1). The Company is also focused on development of Bria-OTS, which is an off-the-shelf personalized immunotherapy based on a patient’s HLA-type. Its other pre- clinical candidates include Bria-Pros, Bria-Lung, Bria-Mel, Bria-TILsRx and others.&lt;br /&gt;
&lt;br /&gt;
==Grafic actiuni companie==&lt;br /&gt;
&amp;lt;iframe key=&amp;quot;tradeville&amp;quot; path=&amp;quot;graficSimbol/US.BCTX&amp;quot; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Ultimele stiri despre BriaCell Therapeutics Corp. (US.BCTX)==&lt;br /&gt;
&amp;lt;dynamicpagelist&amp;gt;&lt;br /&gt;
category=US.BCTX&lt;br /&gt;
count=10&lt;br /&gt;
order=descending&lt;br /&gt;
addfirstcategorydate=false&lt;br /&gt;
&amp;lt;/dynamicpagelist&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Categorie:US.BCTX]][[Categorie:Stiri despre companii]]&lt;/div&gt;</summary>
		<author><name>Admin</name></author>
	</entry>
</feed>